Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2022-04-28 Regulatory Filings
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the expansion of Avicanna's product formulary with new Cannabigerol (CBG) products in the Canadian market. It focuses on product introductions, research collaborations, and market availability timelines. There are no financial statements, regulatory filings, voting results, or management changes discussed. The content is promotional and informative about product development and market strategy rather than a formal financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is best classified as a general regulatory announcement or company news release that does not fit other specific categories, which corresponds to Regulatory Filings (RNS). The document length is over 10,000 characters, so it is not a brief announcement but still lacks financial or regulatory report content.
2022-04-28 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a new exclusive license and supply agreement between Avicanna Inc. and a South American pharmaceutical company. It discusses the company's business focus, product pipeline, and potential financial milestones related to the agreement. There are no financial statements, regulatory filings, or detailed financial data presented. The content is primarily a corporate announcement about a business partnership and licensing deal, not a financial report, regulatory filing, or management discussion. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to a licensing agreement and potential revenue milestones from that agreement.
2022-04-13 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings
2022-04-11 English
Material change report - English.pdf
Regulatory Filings
2022-04-11 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a new exclusive distribution agreement for Avicanna's derma-cosmetics brand Pura H&W into the European Union through a partnership with Bio-Gate AG. It discusses the product portfolio, clinical studies, market strategy, and company background. There are no financial statements, regulatory filings, or detailed financial data presented. The document is a corporate announcement about a commercial partnership and market expansion, not a financial report, earnings release, or regulatory filing. Therefore, it fits best under the category of a general regulatory announcement or miscellaneous corporate news that does not fit other specific categories.
2022-04-05 English
News release - English.pdf
Regulatory Filings
2022-04-01 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.